Aarhus University Seal / Aarhus Universitets segl

The efficacy of midline catheters-a prospective, randomized, active-controlled study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

The efficacy of midline catheters-a prospective, randomized, active-controlled study. / Nielsen, Emma Bundgaard; Antonsen, Louise; Mensel, Camilla; Milandt, Nikolaj; Dalgaard, Lars Skov; Illum, Britta Skov; Arildsen, Hanne; Juhl-Olsen, Peter.

In: International Journal of Infectious Diseases, Vol. 102, 01.2021, p. 220-225.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Nielsen, EB, Antonsen, L, Mensel, C, Milandt, N, Dalgaard, LS, Illum, BS, Arildsen, H & Juhl-Olsen, P 2021, 'The efficacy of midline catheters-a prospective, randomized, active-controlled study', International Journal of Infectious Diseases, vol. 102, pp. 220-225. https://doi.org/10.1016/j.ijid.2020.10.053

APA

Nielsen, E. B., Antonsen, L., Mensel, C., Milandt, N., Dalgaard, L. S., Illum, B. S., Arildsen, H., & Juhl-Olsen, P. (2021). The efficacy of midline catheters-a prospective, randomized, active-controlled study. International Journal of Infectious Diseases, 102, 220-225. https://doi.org/10.1016/j.ijid.2020.10.053

CBE

MLA

Nielsen, Emma Bundgaard et al. "The efficacy of midline catheters-a prospective, randomized, active-controlled study". International Journal of Infectious Diseases. 2021, 102. 220-225. https://doi.org/10.1016/j.ijid.2020.10.053

Vancouver

Nielsen EB, Antonsen L, Mensel C, Milandt N, Dalgaard LS, Illum BS et al. The efficacy of midline catheters-a prospective, randomized, active-controlled study. International Journal of Infectious Diseases. 2021 Jan;102:220-225. https://doi.org/10.1016/j.ijid.2020.10.053

Author

Nielsen, Emma Bundgaard ; Antonsen, Louise ; Mensel, Camilla ; Milandt, Nikolaj ; Dalgaard, Lars Skov ; Illum, Britta Skov ; Arildsen, Hanne ; Juhl-Olsen, Peter. / The efficacy of midline catheters-a prospective, randomized, active-controlled study. In: International Journal of Infectious Diseases. 2021 ; Vol. 102. pp. 220-225.

Bibtex

@article{ba72643bf5f84f498f9e28e501773554,
title = "The efficacy of midline catheters-a prospective, randomized, active-controlled study",
abstract = "OBJECTIVES: We investigated whether an IV strategy based on new generation midline catheters was an efficacious alternative to a conventional IV strategy consisting of peripheral venous catheters and central venous catheters, for patients needing IV therapy exceeding five days.METHODS: This was a prospective, randomised, controlled study. Patients requiring more than five days IV treatment were randomised to either a midline catheter based IV strategy or a conventional strategy. The primary endpoint was composite of the insertion of a CVC or the need for ≥ four PVC insertions. The secondary outcomes included catheter dwell times and reasons for premature removal.RESULTS: 120 patients were included. In the midline group, the fraction of patients receiving ≥ four PVCs or had a CVC inserted was 12/58 (21%) vs. 38/58 (66%) in the conventional group (P < 0.001), number needed to treat: 2.2. Median overall catheter dwell times were 7 days (0-60 days) and 4 days (0-84 days) in the midline- and conventional groups, respectively (P = 0.002).CONCLUSION: In patients requiring more than 5 days of IV therapy, a midline catheter strategy reduced the need for insertion of a CVC or more than 4 PVCs.TRIAL REGISTRATION: ClinicalTrials (NCT03457259).",
author = "Nielsen, {Emma Bundgaard} and Louise Antonsen and Camilla Mensel and Nikolaj Milandt and Dalgaard, {Lars Skov} and Illum, {Britta Skov} and Hanne Arildsen and Peter Juhl-Olsen",
note = "Copyright {\textcopyright} 2020. Published by Elsevier Ltd.",
year = "2021",
month = jan,
doi = "10.1016/j.ijid.2020.10.053",
language = "English",
volume = "102",
pages = "220--225",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier Ltd",

}

RIS

TY - JOUR

T1 - The efficacy of midline catheters-a prospective, randomized, active-controlled study

AU - Nielsen, Emma Bundgaard

AU - Antonsen, Louise

AU - Mensel, Camilla

AU - Milandt, Nikolaj

AU - Dalgaard, Lars Skov

AU - Illum, Britta Skov

AU - Arildsen, Hanne

AU - Juhl-Olsen, Peter

N1 - Copyright © 2020. Published by Elsevier Ltd.

PY - 2021/1

Y1 - 2021/1

N2 - OBJECTIVES: We investigated whether an IV strategy based on new generation midline catheters was an efficacious alternative to a conventional IV strategy consisting of peripheral venous catheters and central venous catheters, for patients needing IV therapy exceeding five days.METHODS: This was a prospective, randomised, controlled study. Patients requiring more than five days IV treatment were randomised to either a midline catheter based IV strategy or a conventional strategy. The primary endpoint was composite of the insertion of a CVC or the need for ≥ four PVC insertions. The secondary outcomes included catheter dwell times and reasons for premature removal.RESULTS: 120 patients were included. In the midline group, the fraction of patients receiving ≥ four PVCs or had a CVC inserted was 12/58 (21%) vs. 38/58 (66%) in the conventional group (P < 0.001), number needed to treat: 2.2. Median overall catheter dwell times were 7 days (0-60 days) and 4 days (0-84 days) in the midline- and conventional groups, respectively (P = 0.002).CONCLUSION: In patients requiring more than 5 days of IV therapy, a midline catheter strategy reduced the need for insertion of a CVC or more than 4 PVCs.TRIAL REGISTRATION: ClinicalTrials (NCT03457259).

AB - OBJECTIVES: We investigated whether an IV strategy based on new generation midline catheters was an efficacious alternative to a conventional IV strategy consisting of peripheral venous catheters and central venous catheters, for patients needing IV therapy exceeding five days.METHODS: This was a prospective, randomised, controlled study. Patients requiring more than five days IV treatment were randomised to either a midline catheter based IV strategy or a conventional strategy. The primary endpoint was composite of the insertion of a CVC or the need for ≥ four PVC insertions. The secondary outcomes included catheter dwell times and reasons for premature removal.RESULTS: 120 patients were included. In the midline group, the fraction of patients receiving ≥ four PVCs or had a CVC inserted was 12/58 (21%) vs. 38/58 (66%) in the conventional group (P < 0.001), number needed to treat: 2.2. Median overall catheter dwell times were 7 days (0-60 days) and 4 days (0-84 days) in the midline- and conventional groups, respectively (P = 0.002).CONCLUSION: In patients requiring more than 5 days of IV therapy, a midline catheter strategy reduced the need for insertion of a CVC or more than 4 PVCs.TRIAL REGISTRATION: ClinicalTrials (NCT03457259).

U2 - 10.1016/j.ijid.2020.10.053

DO - 10.1016/j.ijid.2020.10.053

M3 - Journal article

C2 - 33129962

VL - 102

SP - 220

EP - 225

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -